Evotec to Present at the Jefferies 2016 Global Healthcare Conference (New York)

HAMBURG, Germany–(BUSINESS WIRE)– Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809)
announced today that its CEO, Dr Werner Lanthaler, will present at the
Jefferies 2016 Global Healthcare Conference in New York, USA.

Jefferies 2016 Global Healthcare Conference, New York City, NY, USA

} Date: Wednesday, 08 June 2016, 08.00 am EDT (02.00 pm CEST)

} Venue: New York, NY, USA

} Presenter: Dr Werner Lanthaler, Chief Executive Officer of Evotec AG

The PDF version and the direct link to the webcast of the presentation
will be provided at http://www.evotec.com/.

ABOUT EVOTEC AG

Evotec is a drug discovery alliance and development partnership company
focused on rapidly progressing innovative product approaches with
leading pharmaceutical and biotechnology companies, academics, patient
advocacy groups and venture capitalists. We operate worldwide providing
the highest quality stand-alone and integrated drug discovery solutions,
covering all activities from target-to-clinic to meet the industry’s
need for innovation and efficiency in drug discovery (EVT Execute). The
Company has established a unique position by assembling top-class
scientific experts and integrating state-of-the-art technologies as well
as substantial experience and expertise in key therapeutic areas
including neuroscience, diabetes and complications of diabetes, pain and
inflammation, oncology and infectious diseases. On this basis, Evotec
has built a broad and deep pipeline of more than 70 partnered product
opportunities at clinical, pre-clinical and discovery stages (EVT
Innovate). Evotec has established multiple long-term discovery alliances
with partners including Bayer, CHDI or UCB and development partnerships
with e.g. Janssen Pharmaceuticals in the field of Alzheimer’s disease,
with MedImmune and Sanofi in the field of diabetes, with Pfizer in the
field of tissue fibrosis and with Second Genome in the field of
inflammatory diseases. For additional information please go to www.evotec.com.

FORWARD LOOKING STATEMENTS – Information set forth in this press release
contains forward-looking statements, which involve a number of risks and
uncertainties. The forward-looking statements contained herein represent
the judgement of Evotec as of the date of this press release. Such
forward-looking statements are neither promises nor guarantees, but are
subject to a variety of risks and uncertainties, many of which are
beyond our control, and which could cause actual results to differ
materially from those contemplated in these forward-looking statements.
We expressly disclaim any obligation or undertaking to release publicly
any updates or revisions to any such statements to reflect any change in
our expectations or any change in events, conditions or circumstances on
which any such statement is based.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160601005989/en/